Pulmatrix, Inc. financial data

Symbol
PULM on Nasdaq
Location
Framingham, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 16 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1106% % 71%
Debt-to-equity 10% % -79%
Return On Equity -94% % -49%
Return On Assets -85% % -103%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3,652,285 shares 0%
Common Stock, Shares, Outstanding 3,652,285 shares 0%
Weighted Average Number of Shares Outstanding, Basic 3,652,285 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 3,652,285 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $47,000 USD -100%
General and Administrative Expense $6,169,000 USD -8.6%
Operating Income (Loss) $6,213,000 USD 38%
Nonoperating Income (Expense) $7,000 USD -102%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $6,220,000 USD 36%
Earnings Per Share, Basic 0 USD/shares 73%
Earnings Per Share, Diluted 0 USD/shares 73%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,794,000 USD -56%
Accounts Receivable, after Allowance for Credit Loss, Current $16,000 USD -97%
Assets, Current $4,972,000 USD -57%
Assets $4,982,000 USD -57%
Accounts Payable, Current $69,000 USD -82%
Liabilities, Current $249,000 USD -58%
Liabilities $249,000 USD -58%
Retained Earnings (Accumulated Deficit) $301,390,000 USD -2.1%
Stockholders' Equity Attributable to Parent $4,733,000 USD -57%
Liabilities and Equity $4,982,000 USD -57%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,813,000 USD 33%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 3,652,285 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,813,000 USD 37%
Preferred Stock, Shares Authorized 500,000 shares 0%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $306,123,000 USD 0.01%
Share-based Payment Arrangement, Expense $33,000 USD -95%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%